Therapeutic,Format,CH1 Isotype,VD LC,Highest_Clin_Trial (Jan '23),Est. Status,Heavy Sequence,Light Sequence,Heavy Sequence (if bispec),Light Sequence (if bispec),100% SI Structure,99% SI Structure,95-98% SI Structure,Year Proposed,Year Recommended,Target,Companies,Conditions Approved,Conditions Active,Conditions Discontinued,Development Tech,Notes
Bamlanivimab,Whole mAb,G1,Kappa,Approved,Active,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGYYEARHYYYYYAMDVWGQGTAVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLSWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,na,na,7l3n:DE/7kmg:AB:DE,None,None,2020,2021,SARS-CoV-2 Spike,Abcellera;Eli Lilly and Company;National Institute of Allergy and Infectious Diseases,COVID-19,na,na,Baiting from convalescent human B-cells,
Bebtelovimab,Whole mAb,G1,Lambda,Approved,Active,QITLKESGPTLVKPTQTLTLTCTFSGFSLSISGVGVGWLRQPPGKALEWLALIYWDDDKRYSPSLKSRLTISKDTSKNQVVLKMTNIDPVDTATYYCAHHSISTIFDHWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTATSSDVGDYNYVSWYQQHPGKAPKLMIFEVSDRPSGISNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTTSSAVFGGGTKLTVL,na,na,7mmo:AB:DE,None,None,2022,na,SARS-CoV-2 Spike RBD,Eli Lilly;AbCellera,COVID-19,na,na,na,
Cilgavimab,Whole mAb,G1,Kappa,Approved,Active,EVQLVESGGGLVKPGGSLRLSCAASGFTFRDVWMSWVRQAPGKGLEWVGRIKSKIDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTAGSYYYDTVGPGLPEGKFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLMYWASTRESGVPDRFSGSGSGAEFTLTISSLQAEDVAIYYCQQYYSTLTFGGGTKVEIK,na,na,7l7e:CD:EF:MN:OP/8d8q:HL,None,None,2020,2021,SARS-CoV-2 Spike RBD,AstraZeneca,COVID-19,na,na,na,
Masavibart,Whole mAb,G1,Lambda,Approved,Active,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCASGSDYGDYLLVYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQSEDEADYYCNSLTSISTWVFGGGTKLTVL,na,na,6xdg:CA,None,None,2020,2021,SARS-CoV-2 Spike RBD,Regeneron Pharmaceuticals,COVID-19,na,na,na,Imdevimab is former name for Masavibart
Regdanvimab,Whole mAb,G1,Lambda,Approved,Active,QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,na,na,7cm4:HL,None,None,2020,2021,SARS-CoV-2 Spike RBD,Celltrion,na,COVID-19,na,na,
